Weight-loss drugs may prevent thousands of knee replacements, study suggests

Patients with knee arthritis who took medications for at least three years at reduced risk of needing surgery

Taking weight-loss drugs for at least three years could prevent thousands of knee replacements a year, research suggests.

Globally, more than 500 million people have osteoarthritis. Knee arthritis is the most common form, affecting about 14 million people in the US and more than 5 million in the UK. Many will require knee surgery. In the UK more than 120,000 knee replacements are carried out every year.

Continue reading...

US is ‘simply choosing not to stop’ Ebola outbreak after massive public health cuts, experts say

Hundreds of cases reported in the DRC after USAID has been dismantled and key scientific research canceled

A previously undetected outbreak of Ebola is coursing through parts of central Africa, and the US appears to be doing little to help stop it, after massive cuts to global and domestic public health efforts.

There is no cure and no vaccine for the rare Bundibugyo variant of Ebola, which has caused two outbreaks in recent decades. Health leaders and scientists are now racing to understand where the virus is spreading and attempting to stop it – but the US is notably absent in these efforts.

Continue reading...

‘We’re not ready’: US lags on pandemic preparedness after Covid, experts say

Experts say slashed funding and growing misinformation are some of the greatest challenges facing public health

The hantavirus outbreak, while unlikely to spark the next big pandemic, is shining a spotlight on the ways public health has deteriorated in the US: its ability to test for rare diseases, its expertise on outbreak prevention and response, its ability to battle misinformation and restore trust.

“Assuming everything goes well in containing this outbreak, which I hope it does, the takeaway from that should not be ‘we’re fine,’” said Stephanie Psaki, former White House global health security coordinator. “We’re not ready for this type of threat.”

Continue reading...

Man produces sperm from testicular tissue frozen as a child in breakthrough trial

Exclusive: Sperm re-transplant offers hope that boys left infertile by chemotherapy could have biological children one day

In a groundbreaking fertility trial, a man whose testicular tissue was frozen before he underwent chemotherapy as a child to be re-transplanted 16 years later has been able to produce sperm.

It is the first time a transplant of cryopreserved prepubertal testicular tissue has been demonstrated to restore sperm production in an adult patient. The 27-year-old man had the sample frozen when he was 10, before undergoing potent chemotherapy as part of treatment for sickle cell disease.

Continue reading...

Trial of non-invasive endometriosis scan boosts hopes for quicker diagnosis

Results suggest radiotracer maraciclatide can ‘light up’ condition on scan and reduce need for investigative surgery

A non-invasive scan for endometriosis has shown promising results in a trial, boosting hopes for far quicker diagnosis.

The trial, which included 19 women with the condition, suggests that an experimental radiotracer, called maraciclatide, can “light up” endometriosis on a scan. The current need for a surgical investigation is seen as a major obstacle to timely diagnosis, with women in England typically waiting nearly a decade.

Continue reading...

Knee surgery for cartilage damage does not benefit patients, study suggests

People with meniscus tears who underwent surgery had poorer knee function and worse osteoarthritis after 10 years than those who did not

A common knee surgery for cartilage damage does not benefit patients and may lead to worse outcomes, a 10-year trial suggests.

The study tracked outcomes for patients treated for a meniscus tear, who were given a partial meniscectomy, one of the most common orthopaedic surgeries. Their trajectories were compared with patients who had randomly been assigned to receive “sham surgery”, in which no procedure was carried out.

Continue reading...

Trump announces reforms to accelerate access to psychedelic drug treatments

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine

Donald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs.

The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, which US military veteran groups have said can help treat post-traumatic stress disorder.

Continue reading...

GSK reports promising early results in ovarian and womb cancer drug trial

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug

GSK has revealed positive results for a treatment for gynaecological cancers as its chief executive, Luke Miels, seeks to speed up drug development at the group.

The company said that in an early-stage trial Mocertatug Rezetecan, known as Mo-Rez, shrank or eliminated tumours in 62% of patients with ovarian cancer where chemotherapy had failed, and in 67% of those with endometrial cancer.

Continue reading...

How you walk reveals to others how you are feeling, researchers say

Study highlights the movements in people’s gait that give away most about their emotional state

A long face is not the only sign that someone is down in the dumps. How people walk is revealing too, particularly the swing of the arms and legs, researchers say.

Scientists asked volunteers to guess people’s emotions from video clips of them walking and found that bigger swings portrayed more aggression while smaller swings implied fear and sadness.

Continue reading...

Cannabis is not an effective treatment for common mental health conditions, says review

International researchers find ‘very little evidence’ medical form of the drug can treat anxiety, anorexia and other disorders

Cannabis is not an effective treatment for common mental health conditions despite the global surge in patients using it for that purpose, a review has found.

Researchers concluded there was “very little evidence for its efficacy” in treating anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder or opioid use disorder.

Continue reading...

Weight-loss drugs could prevent fatal complications from heart attacks, UK study finds

Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recovery

Weight-loss drugs could help people who have had a heart attack avoid suffering potentially fatal complications afterwards, research has found.

Drugs such as Ozempic and Wegovy reduce the risk of the tissue damage that affects up to half of the 100,000 people a year in the UK who suffer a heart attack, according to the study.

Continue reading...

Rising anger over ‘lop-sided’ and ‘immoral’ US health funding pacts with African countries

Zimbabwe refuses to sign agreement and Kenya faces a court case over data sharing as new aid deals come under scrutiny

A series of bilateral health agreements being negotiated between African countries and the administration of President Donald Trump have been labelled “clearly lop-sided” and “immoral” amid growing outrage at US demands, including countries being forced to share biological resources and data.

It emerged this week that Zimbabwe had halted negotiations with the US for $350m (£258m) of health funding, saying the proposals risked undermining its sovereignty and independence.

Continue reading...

New drug could be a breakthrough in treatment for killer TB, trial suggests

Sorfequiline shows stronger action than existing treatments against illness that killed 1.23 million last year

A new treatment for tuberculosis could boost cure rates and shorten the time needed to treat the disease by months, trial results suggest.

Globally, an estimated 10.7 million people fell ill with TB last year and 1.23 million died from it.

Continue reading...

US to demand countries share data on ‘pathogens with epidemic potential’ in return for health aid

Draft template seen by the Guardian has no reference to countries receiving benefits for sharing information, such as guaranteed access to medicines developed as a result

The US wants countries to agree to hand over information on bugs that could cause large-scale disease outbreaks in return for restoring aid to tackle health problems such as HIV and malaria, according to government documents.

The Trump administration is seeking new bilateral aid agreements with dozens of countries, after an abrupt withdrawal from existing arrangements at the start of this year. The agreements form part of a new America First Global Health Strategy announced in September.

Continue reading...

Lab monkeys on loose after Mississippi crash were disease-free, university says

Three monkeys remain at large and are being searched for, officials said after initially reporting they were infectious

A group of monkeys being transported on a Mississippi highway that escaped captivity on Tuesday after the truck carrying them overturned did not carry a dangerous infectious disease, a university has said.

The truck was carrying rhesus monkeys, which typically weigh around 16lb (7.7kg) and are among the most medically studied animals on the planet.

Continue reading...

Napoleon’s soldiers who died in Russian retreat had unexpected diseases, study finds

Analysis of DNA from teeth of troops buried in mass grave suggests soldiers had paratyphoid fever and relapsing fever

When Napoleon ordered his army to retreat from Russia in October 1812, disaster ensued. Starving, cold, exhausted and struggling with sickness, an estimated 300,000 soldiers died.

Researchers now say they have identified two unexpected diseases among soldiers who died in the retreat – paratyphoid fever and relapsing fever – which provide fresh insights into their plight.

Continue reading...

Protective immune cells in breastfeeding women identified as guard against breast cancer, new research finds

Patients who had more cells had better outcomes, particularly for aggressive types such as triple-negative breast cancer

In the 18th century, physicians noticed nuns had some of the highest rates of breast cancer. It was one of the earliest clues that led scientists to suspect that child-bearing and breastfeeding could protect against the disease.

Modern data has confirmed the centuries-old observation but the biological reasons behind it have remained unclear. Explanations have often focused on pregnancy-related hormonal changes, but research published Tuesday in Nature has found breastfeeding provides long-lasting immune protection.

Continue reading...

Smart jab can shrink head and neck cancer tumours within six weeks, trial finds

Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers

Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks.

Head and neck cancer is the world’s sixth most common form of the disease. If it spreads or comes back after standard treatment, patients may be offered immunotherapy and platinum chemotherapy. But if this fails, there is often little else doctors can do.

Continue reading...

Nobel prize in medicine awarded to scientists for immune system research

Mary E Brunkow, Fred Ramsdell and Shimon Sakaguchi worked on how the immune system can be prevented from harming the body

The Nobel prize in physiology or medicine 2025 has been awarded to three scientists for their work on how the immune system is kept in check and prevented from attacking our own body.

Mary E Brunkow, Fred Ramsdell and Shimon Sakaguchi have been awarded the prize “for their discoveries concerning peripheral immune tolerance”.

Continue reading...

Huntington’s disease treated successfully for first time in UK gene therapy trial

Surgical procedure to treat devastating illness slowed progress of disease by 75% in patients after three years

Huntington’s disease, a devastating degenerative illness that runs in families, has been treated successfully for the first time in a breakthrough gene therapy trial.

The disease, caused by a single gene defect, steadily kills brain cells leading to dementia, paralysis and ultimately death. Those with a parent with Huntington’s have a 50% chance of developing the disease, which until now has been incurable.

Continue reading...